Ibogaine is a Schedule I substance with zero legal therapeutic access anywhere in the US, so Americans travel abroad for treatment. But Colorado is weighing first-in-the-nation regulated access, and Texas and Mississippi have funded major clinical trials. A verified, regularly updated tracker — with a plain-English cardiac safety warning and the decriminalized-vs-regulated distinction most pages get wrong.
On June 22, 2026, Definium Therapeutics reported that DT120 — an LSD-based dissolving tablet — succeeded in its first pivotal depression trial. Here's the honest version of what a positive Phase 3 readout does and doesn't change for patients seeking treatment today.
Current FDA status of psilocybin after positive 26-week Part B COMP006 results (July 7, 2026). COMP360 rolling NDA timeline, Executive Order 14401, state trigger laws, Phase 3 results, and DEA rescheduling pathway — verified and regularly updated.
A state-by-state analysis of what Trump's April 18, 2026 executive order actually changes for patients seeking psychedelic therapy — and what it doesn't. Covers Oregon, Colorado, New Mexico, Texas, and nationwide ketamine access, with verified timelines for COMP360 psilocybin approval.
What happens before, during, and after your first ketamine infusion — step by step. Covers screening, the experience itself, side effects, cost, and how to choose a clinic. Based on clinical evidence and real patient accounts.
Ketamine therapy costs $400-$800 per session out of pocket. Learn 10 pathways to afford treatment — insurance, HSA/FSA, VA coverage, sliding scale clinics, clinical trials, financing, and more.
Psilocybin therapy is now legal in Oregon, Colorado, and New Mexico, with 26+ states considering legislation in 2026. Connecticut signed its expanded pilot into law, Colorado added an ibogaine research pilot, Minnesota ordered a feasibility study, and the federal approval track accelerated under EO 14401. Updated July 14, 2026.
Compare 10+ at-home ketamine providers side by side — verified pricing from $87–$399/month, safety records, clinical oversight levels, and the regulatory risks the industry doesn't advertise.
Ketamine therapy costs $280–$500 per session depending on modality. Based on pricing data from 613 US clinics tracked by PsychedelicBeacon, here's what every treatment type actually costs in 2026.
A living tracker of every active state and federal bill expanding psilocybin access for PTSD patients in 2026. Updated as bills advance, pass, or fail.
Psilocybin remains experimental for PTSD — but clinical trials are advancing, two states have active legal programs, and a wave of state legislation is moving faster than most people realize. Here's what the evidence actually shows, where you can legally access treatment today, and what it costs.
Ketamine-based treatments for depression have entered a new phase. Here's what the science, FDA approvals, treatment protocols, and costs actually look like in 2026 — and how to find a provider.
Ketamine offers rapid PTSD symptom reduction in small trials, but the largest controlled study in veterans found no benefit over placebo. Here's what the evidence actually shows in 2026, what it costs, and how to find a provider.
South Dakota signed psychedelic therapy legislation on March 10, 2026, and Minnesota lawmakers approved a psilocybin legalization bill the same week. Here's what each law does and what it means for patients.
The U.S. has 1,500+ ketamine clinics but no federal standard governs them. Here's exactly what credentials, questions, and red flags to look for — plus state-by-state guides for California, New York, Colorado, Minnesota, Texas, and Oregon.
Spravato can cost as little as $10/session with the J&J withMe Savings Program while IV ketamine runs $400-$800 out-of-pocket. We compare FDA status, effectiveness data, insurance coverage, and side effects to help you decide.